5-N-methylated quindoline derivatives as telomeric g-quadruplex stabilizing ligands: effects of 5-N positive charge on quadruplex binding affinity and cell proliferation.

A series of 5-N-methyl quindoline (cryptolepine) derivatives (2a- x) as telomeric quadruplex ligands was synthesized and evaluated. The designed ligands possess a positive charge at the 5- N position of the aromatic quindoline scaffold. The quadruplex binding of these compounds was evaluated by circular dichroism (CD) spectroscopy, fluorescence resonance energy transfer (FRET) melting assay, polymerase chain reaction (PCR) stop assay, nuclear magnetic resonance (NMR), and molecular modeling studies. Introduction of a positive charge not only significantly improved the binding ability but also induced the selectivity toward antiparallel quadruplex, whereas the nonmethylated derivatives tended to stabilize hybrid-type quadruplexes. NMR and molecular modeling studies revealed that the ligands stacked on the external G-quartets and the positively charged 5- N atom could contribute to the stabilizing ability. Long-term exposure of human cancer cells to 2r showed a remarkable cessation in population growth and cellular senescence phenotype and accompanied by a shortening of the telomere length.

[1]  Stephen Neidle,et al.  Crystal structure of parallel quadruplexes from human telomeric DNA , 2002, Nature.

[2]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[3]  J. Chaires,et al.  Use of competition dialysis in the discovery of G-quadruplex selective ligands. , 2007, Methods.

[4]  M. Stevens,et al.  Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes. , 2001, Molecular pharmacology.

[5]  L. Hurley,et al.  A DNA polymerase stop assay for G-quadruplex-interactive compounds. , 1999, Nucleic acids research.

[6]  M. Stevens,et al.  Antitumor polycyclic acridines. 17. Synthesis and pharmaceutical profiles of pentacyclic acridinium salts designed to destabilize telomeric integrity. , 2005, Journal of medicinal chemistry.

[7]  C. Laughton,et al.  Antitumor polycyclic acridines. Part 12. Physical and biological properties of 8,13-diethyl-6-methylquino[4,3,2-kl]acridinium iodide: a lead compound in anticancer drug design. , 2002, Oncology research.

[8]  R. Wheelhouse,et al.  Cationic Porphyrins as Telomerase Inhibitors: the Interaction of Tetra-(N-methyl-4-pyridyl)porphine with Quadruplex DNA , 1998 .

[9]  P. Fan,et al.  An alternative synthesis of 10H-indolo[3,2-b]quinoline and its selective N-alkylation , 1997 .

[10]  Jean-Louis Mergny,et al.  Quartets in G‐major , 2007, EMBO reports.

[11]  V A Zakian,et al.  Structure and function of telomeres. , 1989, Annual review of genetics.

[12]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[13]  Kazuo Shin-Ya,et al.  Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex. , 2002, Journal of the American Chemical Society.

[14]  E. Blackburn.  Switching and Signaling at the Telomere , 2001, Cell.

[15]  K. Shin‐ya,et al.  Reevaluation of telomerase inhibition by quadruplex ligands and their mechanisms of action , 2007, Proceedings of the National Academy of Sciences.

[16]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[17]  Patrick Mailliet,et al.  Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase. , 2004, Biochemical and biophysical research communications.

[18]  Lin Ma,et al.  Synthesis and evaluation of quindoline derivatives as G-quadruplex inducing and stabilizing ligands and potential inhibitors of telomerase. , 2005, Journal of medicinal chemistry.

[19]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[20]  N. Sugimoto,et al.  Characterization and thermodynamic properties of quadruplex/duplex competition , 2002, FEBS letters.

[21]  M. Bansal,et al.  Hairpin and parallel quartet structures for telomeric sequences. , 1992, Nucleic acids research.

[22]  P. Imbach,et al.  Antihyperglycemic activities of cryptolepine analogues: an ethnobotanical lead structure isolated from Cryptolepis sanguinolenta. , 1998, Journal of medicinal chemistry.

[23]  J. Huddleston,et al.  Synthesis and preliminary evaluation of novel analogues of quindolines as potential stabilisers of telomeric G-quadruplex DNA , 2007 .

[24]  S. J. Holt,et al.  111. Carbazoles, carbolines, and related compounds. Part I. Quindoline derivatives , 1947 .

[25]  P. Kollman,et al.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.

[26]  T. Cech,et al.  Telomerase and the maintenance of chromosome ends. , 1999, Current opinion in cell biology.

[27]  E. Hwang.  Replicative senescence and senescence-like state induced in cancer-derived cells , 2002, Mechanisms of Ageing and Development.

[28]  Carol W. Greider,et al.  Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.

[29]  D. Case,et al.  Langevin modes of macromolecules: Applications to crambin and DNA hexamers , 1990, Biopolymers.

[30]  E. Raymond,et al.  Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. , 1999, Cancer research.

[31]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[32]  et al.,et al.  The RNA component of human telomerase , 1995, Science.

[33]  J. Mergny,et al.  Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M F Sanner,et al.  Python: a programming language for software integration and development. , 1999, Journal of molecular graphics & modelling.

[35]  Gary Parkinson,et al.  Telomere maintenance as a target for anticancer drug discovery , 2002, Nature Reviews Drug Discovery.

[36]  Jean-Louis Mergny,et al.  Targeting telomeres and telomerase. , 2008, Biochimie.

[37]  O. Fedoroff,et al.  NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. , 1998, Biochemistry.

[38]  Yasuhiko Yamamoto,et al.  Formation of a complex of 5,10,15,20-tetrakis(N-methylpyridinium-4-yl)-21H,23H-porphyrin with G-quadruplex DNA. , 2006, Biochemistry.

[39]  W. Hahn,et al.  Telomerase Maintains Telomere Structure in Normal Human Cells , 2003, Cell.

[40]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[41]  S. Kerwin,et al.  The relationship between ligand aggregation and G-quadruplex DNA selectivity in a series of 3,4,9,10-perylenetetracarboxylic acid diimides. , 2002, Biochemistry.

[42]  Stephen Neidle,et al.  Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation. , 2006, Journal of medicinal chemistry.

[43]  G. Parkinson,et al.  Predictive modelling of topology and loop variations in dimeric DNA quadruplex structures , 2006, Nucleic acids research.

[44]  Jean-Louis Mergny,et al.  Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay. , 2002, Cancer research.

[45]  Stephen Neidle,et al.  Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[46]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[47]  D. Corey,et al.  Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[48]  D. Bearss,et al.  Telomeres and telomerases as drug targets. , 2002, Current opinion in pharmacology.

[49]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[50]  Markus Kaiser,et al.  Fluorescence-based melting assays for studying quadruplex ligands. , 2007, Methods.

[51]  D. Kingston,et al.  Synthesis and biological evaluation of analogues of cryptolepine, an alkaloid isolated from the Suriname rainforest. , 1999, Journal of natural products.

[52]  S Neidle,et al.  Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: structure-activity relationships. , 1999, Journal of medicinal chemistry.

[53]  K. Shin‐ya,et al.  Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase. , 2003, Cancer research.

[54]  B. Guyen,et al.  Synthesis and evaluation of analogues of 10H-indolo[3,2-b]quinoline as G-quadruplex stabilising ligands and potential inhibitors of the enzyme telomerase. , 2004, Organic & biomolecular chemistry.

[55]  R. Deng,et al.  Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines , 2006, Oncogene.

[56]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[57]  W. Wilson,et al.  Telomestatin and diseleno sapphyrin bind selectively to two different forms of the human telomeric G-quadruplex structure. , 2005, Journal of the American Chemical Society.

[58]  M. Teulade‐Fichou,et al.  A Hitchhiker′s Guide to G‐Quadruplex Ligands , 2008 .

[59]  K. Sharp,et al.  Accurate Calculation of Hydration Free Energies Using Macroscopic Solvent Models , 1994 .

[60]  P. Bolton,et al.  Circular dichroism of quadruplex DNAs: applications to structure, cation effects and ligand binding. , 2007, Methods.

[61]  G. Parkinson,et al.  The structure of telomeric DNA. , 2003, Current opinion in structural biology.

[62]  E. Gilson,et al.  Natural and pharmacological regulation of telomerase. , 2002, Nucleic acids research.

[63]  I. Roninson,et al.  Tumor senescence as a determinant of drug response in vivo. , 2002, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[64]  Juan Aymami,et al.  The antimalarial and cytotoxic drug cryptolepine intercalates into DNA at cytosine-cytosine sites , 2002, Nature Structural Biology.